Ulcerative Colitis

Histological remission is an important target for Ulcerative Colitis (UC) treatment. IAG brings proprietary AI-powered assessment to recognize and count cells in the slides acquired from UC patients before and after treatment.
IAG team can score slides using Gabor or Nancy index as well as to provide a detailed map of the cells and counts.  

IAG delivered end-to-end service in UC clinical trials, from protocol design, data collection, quality control and central review with AI or qualified pathology team.

Our expert team will support the development of imaging strategy and selection of the trial endpoints. Once the trial is designed, IAG’s team will select and train the sites, assist with imaging data collection and review.

Reach out to our expert team, as you are designing and planning your trial.

About IAG, Image Analysis Group

IAG is a unique partner to life sciences companies developing new treatment and driving the hope of the up-coming precision medicine. IAG leverages expertise in medical imaging and the power of DYNAMIKA™, our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes.

Acting as imaging Contract Research Organization, IAG’s experts also recognize the significance of a comprehensive approach to asset development. They actively engage in co-development projects with both private and public sectors, demonstrating a commitment to cultivating collaboration and advancing healthcare solutions.

Contact our expert team: imaging.experts@ia-grp.com

Experience: Scoring Systems
  • Nancy score
  • Gabor score
  • Full cell count (neutrophils)
Experience: Imaging
  • Histology
  • Ultrasound

Since 2007, over 2000 articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.


Combining our technologies and business advisory services with promising life science companies has yielded spectacular results over the past five years. As a trusted partner to many biotech and pharma companies, IAG’s team is proud to share your words and quotes.